The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B-Reference-Cited by-同舟云学术

The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B

Published:2010-07-09 Issue:12 Volume:45 Page:1255-1262
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Fujiwara Keiichi,Yasui Shin,Okitsu Koichiro,Yonemitsu Yutaka,Oda Shigeto,Yokosuka Osamu

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-010-0280-y.pdf

Reference25 articles.

1. Editorial. Chemotherapy and hepatitis B. Lancet 1989; ii:1136–7.

2. Nakamura Y, Motokura T, Fujita R, Yamashita T, Ogata E. Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Cancer. 1996;78:2210–5.

3. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol. 1995;13:29–60.

4. Sjogren MH, Hoofnagle JH, Waggoner JG. Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis. Hepatology. 1987;7:582–5.

5. Lam KC, Lai CL, Trepo C, Wu PC. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med. 1981;304:380–6.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Jian Gan powder ameliorates immunological liver injury in mice by modulating the gut microbiota and metabolic profiles;European Journal of Medical Research;2024-04-20

2. Jian Gan powder ameliorates immunological liver injury in mice by modulating the gut microbiota and metabolic profiles;2024-01-22

3. Thirty‐two years' experience of treating fulminant hepatitis in a Japanese single center;Hepatology Research;2023-01-10

4. Glucocorticoid Treatment Strategies in Liver Failure;Frontiers in Immunology;2022-03-16

5. Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis;Frontiers in Pharmacology;2022-02-11